Polymeric nanoparticles in drug delivery systems critical review and concepts

International Journal of Pharmacy and Technology

Volumn 5, Issue 4, 2014, Pages 2809-2823

  Ayre, A P ^a   Pawar, H A ^a   Khutle, N M ^a   Lalitha, K G ^a  

^a Ultra College of Pharmacy   (India)

Author keywords

Biodegradable polymers; Drug delivery; Nanocarriers; Polymeric nanoparticles

Indexed keywords

ALGINIC ACID; CHITOSAN; CYANOACRYLATE; FLUOROURACIL; FLURBIPROFEN; GELATIN; GLIADIN; INDOMETACIN; ISONIAZID; LOPERAMIDE; MITOXANTRONE; NANOPARTICLE; POLY(METHYL METHACRYLATE); POLYALKYL CYANOACRYLATE; POLYANHYDRIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIDE; POLYMER; POLYMETHACRYLIC ACID; PRAZIQUANTEL; PULLULAN; TAMOXIFEN; TOBRAMYCIN; TRICLOSAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHONE DERIVATIVE;

ARTICLE; BIOAVAILABILITY; CONTROLLED RELEASE FORMULATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; HUMAN; IN VIVO STUDY; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY;

EID: 84898766984     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. E. Fattal, C. Vauthier, I. Aynie, Y. Nakada, G. Lambert, C. Malvy, P. Couvreur, Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J Control Release. 1998, 53, pp137-143
2. R. Fernandez-Urrusuno, P. Calvo, C. Remunan-Lopez, J. L. Vila-Jato, M. Alonso, Enhancement of nasal absorption of insulin using chitosan nanoparticles. J. Pharm Res. 1999, 16, pp1576-1581
3. C. A. Farrugia, M. J. Groves, The activity of unloaded gelatin nanoparticles on murine melanoma B16-F0 growth in vivo. J. Anticancer Res. 1999, 19, pp1027-1031.
4. C. A. Farrugia, M. J. Groves, Gelatin behaviour in dilute aqueous solution: designing a nanoparticulate formulation. J Pharm Pharmacol. 1999, 51, pp643-649.
5. I. Aynie, C. Vauthier, H. Chacun, E. Fattal, P. Couvreur, Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 1999, 9, pp301-312
6. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, W. E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001, 70, pp1-20.
7. A. Kumari, S. K. Yadav, S. C. Yadav, Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and surfaces B: Biointerfaces 2010, 75, pp1-18.
8. A. Gessner, C. Olbrich, W. Schröder, O. Kayser, R. H. Müller, The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Int J Pharm. 2001, 214, pp87-91.
9. H. H. Tonnesen, Karlsen, Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads. J. Alginate in drug delivery systems. Drug Dev Ind Pharm. 2002,28, pp621-630
10. M. Rajaonarivony, C. Vauthier, G. Couarraze, F. Puisieux, P. Couvreur, Development of a new drug carrier made from alginate. J Pharm Sci. 1993, 82, pp912-917
11. M. Gonzalez Ferreiro, L. Tillman, G. Hardee, R. Bodmeier, Characterization of alginate/ poly-l-lysine particles as antisense oligonucleotide carriers. Int J Pharm. 2002, 239, pp47-59.
12. S. Wee, W. R. Gombotz, Protein release from alginate matrices. Adv Drug Deliv Rev. 1998, 31, pp267-285
13. A. Zahoor, S. Sharma, G. K. Khuller, Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents. 2005, 26, pp298-303.
14. S. De, D. Robinson, Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. J Control Release. 2003, 89, pp101-112.
15. S. A. Agnihotri, N. N. Mallikarjuna, T. M. Aminabhavi, Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release. 2004, 100, pp5-28.
16. M. Prabaharan, J. F. Mano, Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 2005,12, pp41-57.
17. C. J. Coester, K. Langer, H. V. Briesen, J. Kreuter, Gelatin nanoparticles by two step desolvation a new preparation method, surface modifications and cell uptake. J Microencapsul. 2000, 17, pp187-193.
18. G. Kaul, M. Amiji, Biodistribution and targeting potential of poly (ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J Drug Target. 2004, 12, pp585-591.
19. S. Balthasar, K. Michaelis, N. Dinauer, H. V. Briesen, J. Kreuter, K. Langer, Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials. 2005, 26, pp2723-2732.
20. B. W. Wolf, K. A. Garleb, Y. S. Choe, P. M. Humphrey, K. C. Maki, Pullulan is a slowly digested carbohydrate in humans. J Nutr. 2003, 133, pp1051-1055.
21. M. Gupta, A. K. Gupta, Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J Control Release. 2004, 99: 157-166.
22. R. B. Umamaheshwari, N. K. Jain, Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target. 2003, 11, pp415-423.
23. M. A. Arangoa, M. A. Campanero, M. J. Renedo, G. Ponchel, J. M. Irache, Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharm Res. 2001, 18(11), pp1521-1527.
24. I. Bala, S. Hariharan, M. N. Kumar, PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst. 2004, 21, pp387-422.
25. N. Kumar, R. S. Langer, A. J. Domb, Polyanhydrides: an overview. Adv Drug Deliv Rev. 2002, 54, pp889-910
26. V. R. Sinha, K. Bansal, R. Kaushik, R. Kumria, A. Trehan, Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm. 2004, 278, pp1-23.
27. C. Vauthier, C. Dubernet, C. Chauvierre, I. Brigger, P. Couvreur, Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release. 2003, 93, pp151-160.
28. C. Chauvierre, D. Labarre, P. Couvreur, C. Vauthier, Novel polysaccharide-decorated poly(isobutyl oyanoacrylate) nanoparticles. Pharm Res. 2003,20, pp1786-1793.
29. N. Ubrich, C. Schmidt, R. Bodmeier, M. Hoffman, P. Maincent, Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. Int J Pharm. 2005, 288, pp169-175.
30. J. P. Rao, K. E. Geckeler, Polymer nanoparticles: Preparation techniques and size control parameters. Progress in Polymer science 2011, 36, pp887-913.
31. M. Teixeira, M. J. Alonso, M. M. Pinto, C. M. Barbosa, Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm. 2005, 59: 491.
32. F. Maestrelli, P. Mura, M. J. Alonso, Formulation and characterization of triclosan sub-micron emulsions and nanocapsules. J Microencapsul. 2004, 21, pp857-34.
33. A. Bargoni, R. Cavalli, G. P. Zara, A. Fundaro, O. Caputo, M. R. Gasco, Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution. Pharmacol Res. 2001, 43, pp497-503.
34. D. B. Shenoy, M. M. Amiji, Poly (Ethylene Oxide)-Modified Poly (<-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part I. In Vitro Evaluations. Int J Pharm. 2005, 293, pp261-73.
35. R. M. Mainerdes, R. C. Evangelista, Pharmaceutical Applications of Nanoparticulate Drug-Delivery Systems. J Microencapsul. 2005, 22, pp13-20.
36. C. Alexiou, R. Jurgons, R. J. Schmid, Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target. 2003, 11, pp139-146.
37. AR. N. lyautidin, V. E. Petrov, K. Langer, A. Berthold, D. A. Kharkievich, Delivery of loperamide across the blood brain barrier with polysorbate 80-coated nanoparticles. J. Pharm Res. 1997, 14, pp325-334.
38. R. Pandey, A. Sharma, A. Zahoor, S. Sharma, G. K. Khuller, B. Prasad, Poly (dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother. 2003, 52(6), pp981-986
39. P. Calvo, M. J. Alonso, J. L. VilaJato, J. R. Robinson, Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol. 1996, 48, pp1147-1154
40. F. Castelli, C. Messina, M. G. Sarpietro, R. Pignatello, G. Puglisi, Flurbiprofen Release From Eudragit RS and RL Aqueous Nanosuspensions: a Kinetic Study by DSC and Dialysis Experiments. AAPS Pharm Sci Tech. 2002, 3, pp9-17
41. V. Moutardier, F. Tosini, P. Vlieghe, L. Cara, J. R. Delpero, T. Clerc, Colloidal anticancer drugs bioavailabilities in oral administration models. Int J Pharm. 2003, 260, pp23-31
42. C. Olbrich, O. Kayser, R. H. Muller, Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)- effect of surfactants, storage time and crystallinity. Int J Pharm. 2002, 237, pp119-127
43. V. Venkateswarlu, K. Manjunath, Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004, 95, pp627-638.
44. H. Cabral, N. Nishiyama, S. Okazaki, H. Koyama, K. Kataoka, Preparation and biological properties of dichloro(1,2 diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles. J Control Release. 2005, 101, pp223-232
45. C. Jacobs, R. H. Muller, Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm Res. 2002, 19, pp189-196.
46. Y. Ueno, H. Futagawa, Y. Takagi, A. Ueno, Y. Mizushima, Drug-incorporating calcium carbonate nanoparticles for a new delivery system. J Control Rel. 2005, 103, pp93-105.
47. J. H. Chen, R. Ling, Q. Yao, Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery. World J Gastroenterol. 2004, 10, pp1989-1997.
48. D. J. Brayden, M. A. Jepson, A. W. Baird, Keynote review: intestinal Peyer's patchMcells and oral vaccine targeting. Drug Discov Today 2005, 10, pp1145-1157.
49. S. D. Li, L. Huang, Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 2008, 5, pp496-504.
50. J. S. Crater, R. L. Carrier. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol Biosci 2010, 10, pp1473-1483.
51. G. Nollevaux, C. Deville, M. B. El, W. Zorzi, P. Deloyer, Y. J. Schneider et al. Development of a serum-free coculture of human intestinal epithelium cell-lines (Caco-2/ HT29-5M21). BMC Cell Biol 2006, 7, pp20-28.
52. L. Bromberg, Polymeric micelles in oral chemotherapy. J Control Release 2008, 128, pp99-112.
53. D. E. Owens, N. A. Peppas, Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006, 307, pp93-102.